Sclerobanding in the treatment of second and third degree hemorrhoidal disease in high risk patients on antiplatelet/anticoagulant therapy without suspension: a pilot study

INTRODUCTION: Around 20% of population in western countries is under anticoagulant treatment. However, there is paucity of evidence about the treatment of HD in patients under anticoagulant/antiplatelet therapy, although both suspension and continuation in the perioperative period may increase the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Pata, Francesco, Bracchitta, Luigi M., Nardo, Bruno, Gallo, Gaetano, D’Ambrosio, Giancarlo, Bracchitta, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657801/
https://www.ncbi.nlm.nih.gov/pubmed/38026482
http://dx.doi.org/10.3389/fsurg.2023.1290706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657801/
https://www.ncbi.nlm.nih.gov/pubmed/38026482
http://dx.doi.org/10.3389/fsurg.2023.1290706

Ejemplares similares